Hackenberg, Berit; Doge, Julia; O'brien, Karoline et al.
Psychosocial Work Stress, Resilience and the Risk of Tinnitus-Results from a Population-Based Cohort StudyMEDICINA-LITHUANIA. Bd. 61. H. 12. 2025
Weinmann-Menke, Julia; Gonzalez-Sanchez, Hilda M.; Iwata, Yasunori et al.
Ptprz Signaling, Tubule-Mediated and Macrophage-Mediated Kidney Injury, and Subsequent CKDJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025
Weimer, Johannes; Yilmaz, Didem; Ille, Carlotta et al.
Quality assessment of a training program for undergraduate sonography peer tutors: paving the future way for peer-assisted learning in medical ultrasound educationFRONTIERS IN MEDICINE. Bd. 12. 2025
Labenz, Christian; Gairing, Simon J.; Kaps, Leonard et al.
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosisJHEP REPORTS. Bd. 7. H. 3. 2025
Rodriguez, Isaac; Vellala, Abhinay; Itzel, Timo et al.
Radiomics-based prediction of HCC response to atezolizumab/bevacizumabONCOLOGY LETTERS. Bd. 30. H. 4. 2025
Rodriguez, Isaac; Vellala, Abhinay; Itzel, Timo et al.
Radiomics-based prediction of HCC response to atezolizumab/bevacizumab.JOURNAL OF CLINICAL ONCOLOGY. Bd. 43. H. 4_SUPPL. 2025 S. 636-636
Castven, Darko; Becker, Diana; Castven, Jovana et al.
Rare but not forgotten-comprehensive molecular and histological analysis of the primary yolk sac tumor of the liver and corresponding patient-derived cell lineJOURNAL OF HEPATOLOGY. Bd. 82. 2025
Wegner, Joanna; Gross, Karolin; Ghoreishi, Yalda et al.
Real-world evidence-biosimilars can successfully substitute biologics in psoriasis and hidradenitis suppurativaPOSTEPY DERMATOLOGII I ALERGOLOGII. Bd. 42. H. 5. 2025 S. 488-493
Schleicher, Eva Maria; Uschner, Frank Erhard; Passenberg, Moritz et al.
Real-world outcomes and treatment response to terlipressin in patients with hepatorenal syndrome-acute kidney injury: a multicenter study from the German cirrhosis/Terli-CKD study groupJOURNAL OF HEPATOLOGY. Bd. 82. 2025
Dietz, Julia; Graf, Christiana; Boettler, Tobias et al.
Real-world outcomes in patients with Voxilaprevir (VOX)/ Velpatasvir (VEL)/Sofosbuvir (SOF) treatment failure: a follow-up studyJOURNAL OF HEPATOLOGY. Bd. 82. 2025